Yayınlar & Eserler

Yayın Ağı
Makaleler 4
Tümü (4)
SCI-E, SSCI, AHCI (3)
SCI-E, SSCI, AHCI, ESCI (3)
Scopus (4)

1. Development of Tumour-specific CD146 CAR-T Cells for Targeted Cancer Immunotherapy of Solid Tumours

UZUNER E., Mole H., Gurler S. B., Wong C. W., Carro M. L. F., Leshem R., et al.
CANCER IMMUNOLOGY RESEARCH , sa.10, 2024 (SCI-Expanded, Scopus) identifier

2. RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells

Chen F., Gurler S. B., Novo D., Selli Karakaya Ç., Alferez D. G., Eroglu S., et al.
ONCOGENE , cilt.42, sa.9, ss.679-692, 2023 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

3. The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment.

Uzuner E., Ulu G. T., Gürler S. B., Baran Y.
Methods in molecular biology (Clifton, N.J.) , cilt.2257, ss.375-422, 2022 (Scopus) identifier

4. BSH2020-EP-009 Determination of therapeutic potential of luteolin for Philadelphia chromosome positive acute lymphoblastic leukaemia cells

Gürler S. B.
BRITISH JOURNAL OF HAEMATOLOGY , cilt.189, sa.1, ss.187, 2020 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 5

1. HER2 overexpression initiates breast tumorigenesis non-cellautonomously by altering energy metabolism in the tissue microenvironment

Gurler S. B., Wagstaff O., Dimitrova L., Chen F., Pedley R., Weston W., et al.
AACR Special Conference in Cancer Research: Tumor-body Interactions: The Roles of Micro- and Macroenvironment in Cancer, Massachusetts, Amerika Birleşik Devletleri, 17 - 20 Kasım 2024, (Özet Bildiri) identifier

2. HER2 overexpression initiates breast tumorigenesis non-cell-autonomously by inducing oxidative stress in the tissue microenvironment

Gurler S. B., Wagstaff O., Dimitrova L., Chen F., Pedley R., Weston W., et al.
36th European-Organisation-for-Research-and-Treatment-of-Cancer / National-Cancer-Institute / American-Association-for-Cancer-Research Symposium on Molecular Targets and Cancer Therapeutics (EORTC/NCI/AACR), Barcelona, İspanya, 23 - 25 Ekim 2024, (Özet Bildiri) identifier

3. Development of Tumour-specific CD146 CAR-T Cells for Targeted Cancer Immunotherapy of Solid Tumours

UZUNER E., Mole H., Gurler S. B., Wong C., Carro M. L. F., Leshem R., et al.
36th European-Organisation-for-Research-and-Treatment-of-Cancer / National-Cancer-Institute / American-Association-for-Cancer-Research Symposium on Molecular Targets and Cancer Therapeutics (EORTC/NCI/AACR), Barcelona, İspanya, 23 - 25 Ekim 2024, (Özet Bildiri) identifier

4. HER2 overexpression induces breast tumorigenesis in a non cell autonomous manner by inducing oxidative stress in the tissue microenvironment

Gurler S. B., Wagstaff O., Dimitrova L., Chen F., Pedley R., Weston W., et al.
Annual Meeting of the American-Association-for-Cancer-Research (AACR), California, Amerika Birleşik Devletleri, 5 - 10 Nisan 2024, (Özet Bildiri) identifier

5. Determination of therapeutic potential of luteolin for Philadelphia chromosome positive acute lymphoblastic leukaemia cells

Gurler S. B., Kiraz Y., Baran Y.
60th Annual Scientific Meeting of the British-Society-for-Haematology (BSH), Birmingham, İngiltere, 27 - 29 Nisan 2020, ss.187, (Özet Bildiri) identifier
Kitaplar 2

1. The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment

UZUNER E., GÜRLER S. B., Ulu G. T., BARAN Y.
miRNomics, MicroRNA Biology and Computational Analysis, ALLMER JENS, Yousef Malik, Editör, Springer, New York, ss.375-422, 2021

2. Chapter 21 - Flavonoids in cancer therapy: current and future trends

Gürler S. B., Baran Y.
Biodiversity and Biomedicine Our Future, Dilfuza Egamberdieva,Munir Ozturk,Milica Pešić, Editör, Academic Press Ltd-Elsevier Science Ltd, Massachusetts, ss.403-440, 2020
Metrikler

Yayın

11

Yayın (WoS)

8

Yayın (Scopus)

4

Atıf (WoS)

10

H-İndeks (WoS)

1

Atıf (Scholar)

148

H-İndeks (Scholar)

5

Açık Erişim

1
BM Sürdürülebilir Kalkınma Amaçları